City

Guangzhou (1)

Condition

Classical Hodgkin Lymphoma (1)

Refractory or Relapsed Classical Hodgkin Lymphoma (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Sun Yat-sen University (1)

Collaborator

Intervention

pd-1 inhibitor (1)

pd-1 inhibitor, gemcitabine, vinorelbine and doxorubicin liposome (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

refractory or relapsed classical hodgkin lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Classical Hodgkin Lymphoma, Refractory or Relapsed Classical Hodgkin Lymphoma Trial in Guangzhou (PD-1 inhibitor, PD-1

Recruiting

Classical Hodgkin Lymphoma
Refractory or Relapsed Classical Hodgkin Lymphoma

PD-1 inhibitor
PD-1 inhibitor, gemcitabine, vinorelbine and doxorubicin liposome

Guangzhou, Guangdong, China
+2 more

May 6, 2022